期刊文献+

多发性大动脉炎支架内再狭窄影响因素分析 被引量:2

Influencing factors for restenosis in patients with Takayasu's arteritis
原文传递
导出
摘要 目的探讨多发性大动脉炎(takayasu's arteritis,TA)血管内支架置入术后再狭窄的预测因素及原因,为临床干预提供依据。方法将2000年1月-2011年8月在本院心内科行血管内支架置入术的50例TA患者纳入研究。分为血管内支架置入无狭窄组和再狭窄组,分别比较两组临床基本资料、血管造影影像特征。采用Logistic回归模型分析多发性大动脉炎支架内狭窄的独立危险因素。结果与无狭窄组比较,再狭窄组血清高密度脂蛋白胆固醇(high-density lipoprotein cholesterol,HDL-C)水平较低,置入支架明显较长(P<0.05);介入术后血管残余狭窄>20%在再狭窄组中的比例明显升高,且中度狭窄比例高于无狭窄组(P<0.05)。结论血清HDL-C、支架长度及支架残余狭窄可能是TA患者支架内再狭窄的影响因素。 Objective To study the predictors and reasons for restenosis in patients with Takayasu's arteritis(TA) after stenting in order to provide evidence for its clinical intervention. Methods Fifty TA patients who underwent stenting in our hospital from January 2000 to August 2011 were included in this study. The patients were divided into restenosis group and non-restenosis group. Their clinical data and vascular angiographic findings were compared. Independent risk factors for restenosis in TA patients were analyzed using logistic regression model. Results The serum HDL-C level was significantly lower and the implanted stent was significantly longer in restenosis group than in non-restenosis group(P〈0.05). The proportion of residual stenosis 〉20% and moderate stenosis was higher in restenosis group than in non-restenosis group(P〈0.05). Conclusion Serum HDL-C level, stent length and residual stenosis may be the influencing factors for restenosis in TA patients.
出处 《军医进修学院学报》 CAS 2012年第12期1271-1273,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 多发性大动脉炎 支架内再狭窄 影响因素 Takayasu's arteritis in-stent restenosis influencing factor
  • 相关文献

参考文献14

  • 1Emmans L, Nguyen TM, Laufer N. Percutaneous treatment of severe carotid stenosis due to Takayasu' s arteritis early after carotid endarterectomy [ J ] . J Invasive Cardiol, 2007, 19 ( 9 ) : E258- E260.
  • 2潘长江,王进,黄楠.血管支架内再狭窄的研究进展[J].中国生物医学工程学报,2004,23(2):152-156. 被引量:26
  • 3Sharma BK, Jain S, Suri S, et al. Diagnostic criteria for Takayasu arteritis [ J ]. Int J Cardiol, 1996, 54 ( 0 ) : S127-S133.
  • 4Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis [ J ] . Ann Intern Med, 1994, 120 ( 11 ) : 919-929.
  • 5Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program ( NCEP ) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults ( Adult Treatment Panel III ) [ J ]. JAMA, 2001,285 ( 19 ): 2486-2497.
  • 6Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels : results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study [ J ] . JAMA, 1998, 279 ( 20 ) : 1615-1622.
  • 7Numano F. Vasa vasoritis, vasculitis and atherosclerosis [ J ] . Int J Cardiol. 2000. 75 ( Sunol 1 ) : S1-S8.
  • 8Numano F, Kishi Y, Tanaka A, et al. Inflammation and atherosclerosis. Atherosclerotic lesions in Takayasu arteritis [ J ] . Ann N Y Acad Sci, 2000, 902 : 65-76.
  • 9Numano F, Okawara M, Inomata H, et al. Takayasu's arteritis [ J ] . Lancet, 2000, 356 (9234):1023-1025.
  • 10Filer A, Nicholls D, Corston R, et al. Takayasu arteritis and atherosclerosis : illustrating the consequences of endothelial damage [ J ] . J Rheumatol, 2001, 28 ( 12 ) : 2752-2753.

二级参考文献30

  • 1Dotter CT, Judkins MD. Transluminal treatment of arteriosclerotic obatruction: a new technique and a preliminary report of its application[J]. Circulation,1964,30:654.
  • 2Dotter CT. Transluminally placed coil spring endoarterial tube grafts, long term patency in canine politeal artery[J]. Invest Radiol,1969,4:327.
  • 3Baurschmidt P, Schaldach M. Electrochemical aspects of the thrombogenicity of a materials[J]. J Bioengng,1997,1(11):261.
  • 4Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal grafting[J]. Radiology,1986,160:723.
  • 5Gunn J, Malik N, Shepherd L, et al. In-stent restenosis: more metal and more symmetry required[J]. Heart,1997,77:46.
  • 6E Regar, G Sianos, PW Serruys. Stent development and local drug delivery[J]. British Medical Bulletion,2001,59:227.
  • 7Mehran R, Dangas G, Abizaid A, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome[J]. Circulation,1999,100:1872.
  • 8Mach F. Toward new therapeutic strategies against neointimal formation in restenosis. Atheroscler Thromb Vasc Biol,2000,20:1699.
  • 9Mudra H, Regar E, Klauss V, et al. Serial follow-up after optimized ultrasound guided deployment of Palmaz-Schatz stents[J]. Circulation,1997,95:363.
  • 10Hoffman R, Minta GS, Dussaillant RG, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study[J]. Circulation,1996,94:1247.

共引文献25

同被引文献13

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部